Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-24

Clinical Trial Update: An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating fluticasone propionate nasal spray versus placebo in allergic rhinitis and allergic conjunctivitis; study completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone Propionate Nasal Spray (Fluticasone propionate nasal spray)

Snippet

Sponsor: ORA, Inc. | Conditions: Allergic Rhinitis, Allergic Conjunctivitis | Phase 4 | Status: COMPLETED | Results posted: 2021-03-24